Report Overview

The global automated microbiology market was pegged at US$ 5.0 billion in 2021 and is expected to witness a CAGR of 8.8% during the forecast period.

Market Fundamentals 

Healthcare is heavily reliant on microbiology; hence a variety of labs and process automation solutions are in high demand. In short, automation of microbiological labs increases the dependability of the results while also reducing time. Products including automation tools, automated culture systems, microbiological analyzers, and others are available on the market. Furthermore, Automated microbiology is a cutting-edge technique for providing more rapid, accurate, and effective test results in microbiological research and development. With its rapid results, illnesses like Ebola, chickenpox, smallpox, rubella, measles, mumps, influenza, and others can be quickly identified. In the biological, ecological, and food industries, important functions like microbial separation, detection, categorization, and measurement are automated by this technology.

Market Dynamics

[457383]

The rising incidence of disease caused on by viruses is predicted to fuel growth in the global automated microbiology market over the course of the forecast period. Automated microbiology has gained tremendous growth in recent years for the identification of pathogens as it helps in the early detection of numerous infectious agents including parasites, viruses, prion, fungi, bacteria, and prion-like organisms. Furthermore, other important factors for the growth of the global automated microbiology market include the increasing emphasis on automation advancement in laboratory settings, the increasing demand for error-free test results from the microbiological tests, and the increasing volume of investments made to advance the field of microbiology research.

Market Ecosystem

The global automated microbiology market has been analysed into three perspectives by technology, end user and region.

Automated Microbiology Market by Technology

[987654]

Based on technology, the global automated microbiology market has been segmented into DNA sequencing, DNA & RNA probe technology, detection techniques, immunoassays, and monoclonal antibodies. The DNA and RNA probe technology segment is sub segmented into amplification methods and labelling techniques whereas detection techniques are further divided into, non-isotopic methods and radioactive methods.  The monoclonal antibodies had the largest market share and hence dominated the segment during forecast period due to their extensive use in generating parent cell clones that are used in the detection of disease or infected cells. The increased use of monoclonal antibodies to understand and track disease biology, improve or mimic the immune system's attack on cancer cells, and detect contaminated cells or diseases early and quickly. Monoclonal antibodies are reliable clinical research instruments and are now often employed in therapeutic and diagnostic procedures.

Automated Microbiology Market by End User

Based on end user, the global automated microbiology market has been segmented into biotechnology industries, clinical laboratories, hospitals laoratories, and blood banks. Clinical laboratories have the largest market share of all of the segments. The relatively large number of microbiology studies carried out in labs for the detection of different infectious agents is the main element contributing to the domination of this market.

Automated Microbiology Market by Region

Based on the region, the global automated microbiology market has been segmented into North America, Europe, Asia Pacific, and Rest of the World.  North America dominated the market due to the region's extensive usage of cutting-edge technology and the launch of improvements in molecular diagnostic procedures such genetic probes. Moreover, the Asia Pacific will have profitable growth during the projected period as a result of the region's healthcare infrastructure's rapid improvement over the next seven years. Furthermore, it is anticipated that this region's increased need for technologically advanced goods will accelerate its rise.

The second-largest revenue share in the global market was accounted for by Europe. In the coming years, it is anticipated that the high prevalence of chronic diseases and the rising need for sophisticated diagnostic procedures would continue to propel market revenue growth.

Competitive Landscape

Some of the prominent market players in the global automated microbiology market include 

• Bio-Rad Laboratories, Inc.
• BioMeriux, Inc.
• QIAGEN GmbH
• Becton Dickinson & Company
• Beckman Coulter
• Agilent Technologies, Inc.
• Gene-Probe, Inc.
• Beckman Coulter
• Affymetrix, Inc.
• Danaher Corporation
• Bruker Corporation
• Gene-Probe, Inc.
• Alere Inc.
• Abbott Laboratories. 

Several significant players are concentrating on implementing various business tactics to increase their current customer base. One of the main strategies used by the participants is the introduction of new products, as well as innovations in the current system, collaboration, and mergers and acquisitions.

Strategic development

• In January 2021, an automated RNA extraction procedure was introduced by HiMedia Laboratories. With this kit, scientists can analyse 96 samples in just 11 minutes. The pre-filled reagents in this kit improve the workflow for any COVID testing facility in these difficult times, enabling a multi-fold improvement in testing capacity in terms of speed.
• In November 2019, BD Kiestra IdentifA system was introduced by Becton, Dickinson and Company. This method accurately and effectively gets samples ready for microbiological identification. It takes a lot of work to find the bacteria that is causing an infection. Using the BD Kiestra IdentifA, the lab technician chooses distinct bacterial colonies from a digital plate image using BD Synapsys informatics. The chosen organisms are then physically selected by sophisticated robots, which also prepared the sample for precise identification tests.

Frequently Asked Questions About This Report